Compania de Minas Buenaventura SAA (BVN) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. Despite the recent price drop, the company has shown exceptional financial performance in the latest quarter, strong revenue and net income growth, and positive production trends. The stock is undervalued compared to its potential, and analysts have raised price targets, indicating confidence in its future performance.
The stock's technical indicators present a mixed picture. The MACD is negative and expanding downward, indicating bearish momentum. RSI is neutral at 35.565, not signaling overbought or oversold conditions. However, the moving averages (SMA_5 > SMA_20 > SMA_200) are bullish, suggesting a longer-term uptrend. The stock is trading near its S1 support level of 36.991, which could provide a potential entry point for long-term investors.

Exceptional Q4 2025 financial performance: Revenue increased by 108.08% YoY, net income surged by 1041.21% YoY, and EPS grew by 1061.54% YoY.
Increased production of silver, lead, and zinc.
Analysts have raised price targets, with Scotiabank increasing the target to $44, reflecting confidence in the company's projects and growth potential.
The company is ramping up its San Gabriel operation and advancing its Coimolache Sulfides Project study, which could further enhance its portfolio.
Recent price drop of -5.29% in the regular market and -1.50% in pre-market trading, indicating short-term bearish sentiment.
MACD shows negative momentum, and the stock is trading below its pivot level of 40.
No significant hedge fund or insider trading activity, suggesting a lack of strong institutional support.
In Q4 2025, Buenaventura reported outstanding financial results: Revenue increased to $623.4 million, up 108.08% YoY. Net income surged to $383.6 million, up 1041.21% YoY. EPS rose to $1.51, up 1061.54% YoY. Gross margin improved significantly to 57.68%, up 84.58% YoY. This demonstrates strong operational efficiency and profitability.
Analysts have raised price targets for BVN, with Scotiabank increasing the target from $27 to $42 in January 2026 and further to $44 in March 2026. The firm maintains a Sector Perform rating, citing confidence in the company's growth initiatives, including the San Gabriel operation and Coimolache Sulfides Project study.